ModelEdge

Jounce Therapeutics Inc
0001640455
Filing Type8-K
Filing Date5/3/2023
Updated5/4/23, 1:22 AM

Filing

8-K
Earnings Release

Exhibits

8-KEnd of Material Contract, Completing Asset Acquisition or Sale, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modifications to Rights of Security Holders, Change in Company Ownership, Changes in Board, Management or Compensation, Amendments to Articles of Incorporation or Bylaws
EX-3.1EX-3.1
EX-3.2EX-3.2
EX-10.1EX-10.1
GRAPHIC